Form 4: Lb Pharmaceuticals Executive Receives Stock Grant
Insider Transaction (Form 4)
Susan Gani Kozauer, Chief Medical Officer of Lb Pharmaceuticals Inc, received 200,000 shares of common stock on October 9, 2026.
Summary
- Grant/award: acquired 200,000 Emplopyee Stock Option (Right to Buy) on October 9, 2026; holds 200,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Susan Gani Kozauer — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-09 | Grant/award | Emplopyee Stock Option (Right to Buy) | 200,000 | — | — | 200,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-09 | Grant/award (200,000 shares) |
Keywords
insider transaction, Form 4, LBRX, LB PHARMACEUTICALS INC, neutral, Susan Gani Kozauer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.